Holster Sign
Holster Sign is a classic cutaneous marker of dermatomyositis (DM).
Definition
A violaceous-to-erythematous, macular or patchy rash over the lateral aspects of the hips and upper thighs, corresponding anatomically to the area where a pistol holster would rest.
Clinical Characteristics
- Location:
- Lateral hips
- Proximal lateral thighs
- Morphology:
- Confluent erythematous or violaceous patches
- May show poikiloderma (atrophy, telangiectasia, pigmentary change) in chronic disease
- Symmetry: Typically bilateral
- Photosensitivity: Often present
Pathophysiology
Dermatomyositis is an immune-mediated microangiopathy involving:
- Complement-mediated damage to endomysial capillaries
- Perifascicular muscle fiber atrophy
- Interface dermatitis in skin
Holster sign represents cutaneous vasculopathy and inflammation in photo-exposed or friction-prone areas.
Diagnostic Context
Holster sign is a cutaneous clue to dermatomyositis, especially when accompanied by:
- Heliotrope rash
- Gottron papules
- Shawl sign
- V-sign
- Mechanicโs hands
- Proximal symmetric muscle weakness
- Elevated CK, aldolase
- Myositis-specific antibodies (e.g., anti-Mi-2, anti-TIF1-ฮณ, anti-MDA5)
Important Exam Pearls (High-Yield)
- Seen in both classic dermatomyositis and amyopathic dermatomyositis
- Presence of TIF1-ฮณ antibody + Holster sign โ raise suspicion for malignancy-associated DM
- Often part of poikiloderma atrophicans vasculare
Differential Diagnosis
- Photosensitive drug eruption
- Cutaneous lupus erythematosus
- Chronic actinic dermatitis
- Eczema (distribution usually differs)
Q1. The primary pathophysiological substrate of Holster sign is:
A. CD8+ mediated myofiber necrosis
B. Complement-mediated microangiopathy (C5b-9 deposition)
C. Immune complex vasculitis
D. IgE-mediated mast cell activation
Dermatomyositis involves complement-mediated capillary injury causing perifascicular atrophy.
Q2. Anti-TIF1-ฮณ positivity with Holster sign most strongly predicts:
A. Severe ILD
B. Cardiac arrhythmia
C. Occult malignancy
D. IBM overlap
Anti-TIF1-ฮณ is strongly associated with malignancy-associated dermatomyositis.
Q3. Skin biopsy in Holster sign typically shows:
A. Linear IgG deposition
B. Interface dermatitis with dermal mucin
C. Granulomatous vasculitis
D. Subcorneal pustules
Classic cutaneous DM shows interface dermatitis with mucin deposition.
Q4. Prominent cutaneous DM with Holster sign is classically associated with:
A. Anti-SRP
B. Anti-Mi-2
C. Anti-HMGCR
D. Anti-cN1A
Anti-Mi-2 correlates with florid cutaneous manifestations.
Q5. Holster sign distribution reflects involvement of:
A. Flexural regions
B. Random vascular zones
C. Photosensitive & friction-prone areas
D. High eccrine density sites
Holster sign occurs in photosensitive and mechanically exposed regions.
Q6. Anti-MDA5 DM with Holster sign predicts:
A. Rapidly progressive ILD
B. Calcinosis
C. Statin necrotizing myopathy
D. IBM
Anti-MDA5 is linked to rapidly progressive ILD.
Q7. Anti-NXP2 DM carries increased risk of:
A. Severe ILD
B. Myocarditis
C. CNS vasculitis
D. Malignancy & calcinosis
Anti-NXP2 is linked with calcinosis and malignancy risk.
Q8. Initial malignancy screening in DM should include:
A. PET-CT for all
B. Tumor markers alone
C. Age-appropriate screening + targeted imaging
D. Whole body MRI
Guidelines recommend structured, age-based screening.
